UBS Group’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
WA
UBS Group's TELA Position: Q3 2026 in Review
UBS Group reduced its TELA Bio (TELA) stake by 53% in Q3 2026, selling an estimated $15.1K and leaving 15,756 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8576.
UBS Group first reported a position in TELA in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.56M in Q4 2023. 48 funds tracked by Wall St. Rank hold TELA as of Q3 2026.
- UBS Group held 15,756 shares of TELA Bio worth $18.1K as of Q3 2026.
- UBS Group sold 17,710 TELA Bio shares in Q3 2026, an estimated $15.1K.
- TELA Bio made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8576 holding.
- UBS Group first reported a position in TELA Bio in Q4 2019 and has held it in 27 quarters since.
- UBS Group's TELA Bio position peaked at $4.56M in Q4 2023.
- 48 funds tracked by Wall St. Rank held TELA Bio as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.